Seasonal influenza virus vaccine high dose - Sanofi Pasteur
Alternative Names: Fluzone HD; Fluzone® High Dose IM; Fluzone® High-Dose influenza vaccine; Seasonal influenza virus vaccine - sanofiLatest Information Update: 15 Jul 2025
At a glance
- Originator sanofi pasteur
- Developer Peter MacCallum Cancer Centre; Sanofi; Sanofi K.K.
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Influenza virus infections
Most Recent Events
- 24 Jun 2025 Sanofi Pasteur completes a phase III trial in Influenza virus infections (Prevention, In adults) in USA (IM) (NCT06641180)
- 04 Nov 2024 Phase-III clinical trials in Influenza virus infections (Prevention, In adults) in USA (IM) (NCT06641180)
- 19 Oct 2024 Sanofi Pasteur plans a phase III trial in Influenza virus infections (In adults, Prevention) (IM) (NCT06641180)